Modulations in the ATPases during ketamine-induced schizophrenia and regulatory effect of “3-(3, 4-dimethoxy phenyl) -1- (4-methoxyphenyl) prop-2-en-1-one”: anin vivoandin silicostudies-Reference-Cited by-同舟云学术

Modulations in the ATPases during ketamine-induced schizophrenia and regulatory effect of “3-(3, 4-dimethoxy phenyl) -1- (4-methoxyphenyl) prop-2-en-1-one”: anin vivoandin silicostudies

Published:2020-02-02 Issue:2 Volume:40 Page:148-156
ISSN:1079-9893
Container-title:Journal of Receptors and Signal Transduction
language:en
Short-container-title:Journal of Receptors and Signal Transduction

Author:

Venkataramaiah Chintha¹

Affiliation:

1. Division of Molecular Biology, Department of Zoology, Sri Venkateswara University, Tirupati, India

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10799893.2020.1720242

Reference59 articles.

1. Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

2. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

3. Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence

4. Mitochondrial involvement in psychiatric disorders

5. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antioxidant Properties Mediate Nephroprotective and Hepatoprotective Activity of Essential Oil and Hydro-Alcoholic Extract of the High-Altitude Plant Skimmia anquetilia;Antioxidants;2023-05-28

2. Schizophrenia as metabolic disease. What are the causes?;Metabolic Brain Disease;2023-01-19

3. Phytochemistry and pharmacology of Celastrus paniculatus Wild.: a nootropic drug;Journal of Complementary and Integrative Medicine;2021-09-15

4. Pharmacological Potentiality of Bioactive Flavonoid against Ketamine Induced Cell Death of PC 12 Cell Lines: An In Vitro Study;Antioxidants;2021-06-09

5. Therapeutic potentiality of a new flavonoid against ketamine induced glutamatergic dysregulation in schizophrenia: In vivo and in silico approach;Biomedicine & Pharmacotherapy;2021-06